ID

18868

Description

Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

Keywords

  1. 11/15/16 11/15/16 -
  2. 11/23/16 11/23/16 -
Uploaded on

November 23, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC-ND 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

WTZ-GIST-09-01 (Imatinib + LBH589) Cover Sheet 2009-011417-24 DRKS00000657

WTZ-GIST-09-01 (Imatinib + LBH589) Cover Sheet 2009-011417-24

Patient Data
Description

Patient Data

Alias
UMLS CUI-1
C2707520
Patient No.
Description

Patient number

Data type

text

Alias
UMLS CUI [1]
C2348585
Cohort
Description

Cohort

Data type

integer

Alias
UMLS CUI [1]
C0599755

Similar models

WTZ-GIST-09-01 (Imatinib + LBH589) Cover Sheet 2009-011417-24

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Patient Data
C2707520 (UMLS CUI-1)
Patient number
Item
Patient No.
text
C2348585 (UMLS CUI [1])
Item
Cohort
integer
C0599755 (UMLS CUI [1])
Code List
Cohort
CL Item
10 mg LBH589 (-1)
CL Item
20 mg LBH589 (0)
CL Item
30 mg LBH589 (1)
CL Item
40 mg LBH589 (2)

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial